Cardiology
Service
Juan J.
Gómez Doblas
Publications by the researcher in collaboration with Juan J. Gómez Doblas (34)
2023
-
Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes
Journal of Clinical Medicine, Vol. 12, Núm. 12
-
Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain
Journal of Clinical Medicine, Vol. 12, Núm. 16
-
Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study
Clinical Cardiology, Vol. 46, Núm. 11, pp. 1390-1397
-
Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020
Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 519-530
2022
-
Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice
Revista Española de Cardiología (English Edition), Vol. 75, Núm. 5, pp. 364-369
-
Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing
Journal of Clinical Medicine, Vol. 11, Núm. 20
-
Spanish citizens’ opinions on future trends in cardiology as expressed in digital ecosystems
Humanities and Social Sciences Communications, Vol. 9, Núm. 1
-
Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 1, pp. 4-11
2021
-
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19
Age and ageing, Vol. 50, Núm. 2, pp. 326-334
-
Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice
REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry
Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966
-
Tratamiento hipolipemiante en los pacientes con enfermedad cardiovascular de riesgo muy elevado. Documento de consenso SEC sobre las indicaciones de los iPCSK9 en la práctica clínica
REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48
2020
-
A Delphi consensus on the management of oral anticoagulation in patients with nonvalvular atrial fibrillation in Spain: ACOPREFERENCE study
PLoS ONE, Vol. 15, Núm. 6
-
Baseline ECG and Prognosis After Transcatheter Aortic Valve Implantation: The Role of Interatrial Block
Journal of the American Heart Association, Vol. 9, Núm. 22, pp. e017624
-
Reducing residual thrombotic risk in patients with peripheral artery disease: Impact of the COMPASS trial
Drugs in Context, Vol. 9
-
Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition
Expert Review of Clinical Pharmacology, Vol. 13, Núm. 7, pp. 695-706
2019
-
Abordaje integral del paciente con diabetes mellitus tipo 2 y enfermedad cardiovascular o de muy alto riesgo cardiovascular
REC: CardioClinics, Vol. 54, Núm. 3, pp. 183-192
-
Comprehensive approach to the patient with diabetes mellitus and cardiovascular disease or very high cardiovascular risk
REC: CardioClinics, Vol. 54, Núm. 3, pp. 183-192
-
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
Thrombosis Journal, Vol. 17, Núm. 1
-
Prognosis of Patients With Severe Aortic Stenosis After the Decision to Perform an Intervention
Revista Espanola de Cardiologia, Vol. 72, Núm. 5, pp. 392-397